EdiGene | Genome Editing for a Better Life

Edit Code of Life,Creating Transformative Solutions for Serious Human Diseases

> News> All

News

03
2023-05

EdiGene to Unveil Promising Preclinical POC Data for LEAPER 2.0-based in vivo RNA Editing Therapies in NHP Model at the 26th Annual Meeting of ASGCT via Oral Presentation

LEARN MORE
18
2022-03

EdiGene Acquires Technology from US Hospital to Advance Hematopoietic Stem Cell Therapy

BioWorld - Doris Yu

LEARN MORE
14
2022-02

Improving RNA Editing for Genetic Diseases by Recruiting the Body's Natural Protein

Fierce Biotech - Angus Liu

LEARN MORE
01
2021-12

In Editing RNA, Researchers See Endless Possibilities

The Scientist - Christie Wilcox

LEARN MORE
23
2021-10

RNA-editing race intensifies as Big Pharma buys in

C&EN - Ryan Cross

LEARN MORE
13
2020-10

EdiGene Raises $67M to Take Gene-editing Therapies into Humans

Fierce Biotech - Nick Paul Taylor

LEARN MORE
18
2022-11

EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial of ET-01, its Investigational Gene-editing Hematopoietic Stem Cell Therapy for Transfusion Dependent β-thalassemia

LEARN MORE
08
2022-11

EdiGene Biotechnology Moves into New R&D Center at Waltham, Mass. to Advance Proprietary LEAPER™ Technology into Transformative in vivo RNA Editing Therapies

LEARN MORE
03
2022-11

EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

LEARN MORE
03
2022-05

EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA Editing Efficiency and Outcomes for Therapeutic Development at the ASGCT 25th Annual Meeting

LEARN MORE

1
2
3
4

Follow us on WeChat

Contact Us

Careers : hr@EdiGene.com
Partnership : bd@EdiGene.com
Media Inquiries : media@EdiGene.com

About Us

Company Overview Scientific Founder Leadership Contact Us

Our Business

Gene Editing Our Pipeline Our Focus

News

Press Releases In the Media

Careers

Company Culture Join Us

Copyright © 2020 EdiGene Inc. All Rights Reserved.